Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On March 30, 2022, Alfred Altomari, the Chairman of the Board of Directors (the
"Board") of Baudax Bio, Inc. (the "Company"), notified the Company of his intent
to resign from the Board immediately following the Company's 2022 Annual Meeting
of Shareholders (the "Annual Meeting"). On May 4, the Company held its Annual
Meeting, but adjourned until May 18, 2022 at 9:00 A.M. Eastern Time to allow
more time to establish a quorum.
In light of the adjournment of the Annual Meeting, Mr. Altomari updated his
resignation to be effective as of May 4, 2022. Mr. Altomari's decision to resign
did not result from any disagreement with the Company on any matters relating to
the Company's operations, policies or practices. The Company extends its deepest
gratitude to Mr. Altomari for his distinguished service to the Board and lasting
contributions to the Company.
In addition, effective on May 2, 2022, the Board appointed Mr. Wayne Weisman as
the Chairman of the Board.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses